Octagon Capital Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-185,669
| Closed | -$1.97M | – | 40 |
|
|
2023
Q2 | $1.97M | Hold |
185,669
| – | – | 0.27% | 34 |
|
|
2023
Q1 | $1.55M | Sell |
185,669
-577,787
| -76% | -$4.81M | 0.22% | 32 |
|
|
2022
Q4 | $7.05M | Hold |
763,456
| – | – | 1.1% | 21 |
|
|
2022
Q3 | $9.8M | Hold |
763,456
| – | – | 1.69% | 14 |
|
|
2022
Q2 | $10.1M | Sell |
763,456
-50,000
| -6% | -$660K | 2.69% | 8 |
|
|
2022
Q1 | $17.1M | Buy |
813,456
+29,687
| +4% | +$625K | 3.7% | 9 |
|
|
2021
Q4 | $18.8M | Buy |
783,769
+486,947
| +164% | +$11.7M | 3.66% | 9 |
|
|
2021
Q3 | $7.55M | Hold |
296,822
| – | – | 1.86% | 16 |
|
|
2021
Q2 | $9.99M | Buy |
+296,822
| New | +$9.99M | 2.07% | 16 |
|